Skip to main content

Lakefront Biotherapeutics NV

LKFT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001421876

No open-market purchases or sales by Lakefront Biotherapeutics NV insiders were filed in the last 90 days; 76 institutions reported holding it in 13F filings for Q2 2026, worth $960.3M in total; Greenlight Capital is the only superinvestor holding it.

Other share classesGLPGF

Q2 2024 vs. Q1 2024

How the institutions holding Lakefront Biotherapeutics NV changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of LKFT: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders8385+2
Shares20.5M19.9M−550.8K (−2.7%)
Value$659.6M$494.0M−$165.6M (−25.1%)

New holders (12)

Institutions that held Lakefront Biotherapeutics NV at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to LKFT in Q2 2024
InstitutionSharesValue% of portfolio
Tang Capital Management LLC55,609$1.38M0.14%
Campbell & CO Investment Adviser LLC19,883$492.7K0.04%
Creative Planning18,407$456.1K0.00%
Old Mission Capital LLC14,124$350.0K0.01%
Marshall Wace, LLP12,715$315.1K0.00%
XTX Topco Ltd11,452$283.8K0.02%
Prelude Capital Management, LLC8,632$213.9K0.02%
Mirae Asset Global Investments Co., Ltd.607$15.3K0.00%
Ronald Blue Trust, Inc.271$8.73K0.00%
Allworth Financial LP155$4.05K0.00%
Farther Finance Advisors, LLC77$1.93K0.00%
CIBC Private Wealth Group, LLC11$2830.00%

Sold out (10)

Institutions that held Lakefront Biotherapeutics NV at the end of Q1 2024 and filed for Q2 2024 without it.